The effects of Kechuang Bio's lithium metal electrodes on lithium batteries have been documented by various battery manufacturers.
Kechuang Bio's only requirement is that the new lithium batteries must be supplied to Chinese automakers first, and that it will not consider supplying foreign automakers or joint venture automakers for the first two years.
A strong technological foundation can grant absolute power of discourse.
The battery capacity is tripled, the charging speed is doubled, and the safety is even better than that of ordinary lithium batteries.
Faced with technological advantages, mainstream battery manufacturers had no choice but to accept Kechuang Bio's demands.
They don't sign, but some manufacturers do. In the past two years, new energy has become very popular, and many companies whose main business is not batteries have also rushed to expand their battery production capacity.
Companies eager to ride the wave of scientific and technological innovation in the biotechnology industry are as numerous as carp crossing a river.
Finally, amidst the struggle for interests among various forces, Kechuang Bio signed patent licensing agreements with major battery cathode material manufacturers and some battery manufacturers.
The license only covers the lithium metal cathode portion; for the crucial graphene coating, only the graphene coating manufacturing equipment will be sold, and the patent will not be licensed.
"We have already drawn the 3D rendering of the graphene coating of Kechuang Biotechnology. The problem is how to achieve industrial production. We have no clue."
"Let alone industrial production, even replicating it in the laboratory is currently impossible. We need at least six months."
"Then we can only buy equipment from Kechuang Biotechnology, which costs 2 billion yuan per unit. In addition, there are patent licensing fees for lithium metal. Manufacturing is really not as profitable as scientific research."
"Science and Technology Innovation Biotechnology has been licensing its technology patents for so many years, but we haven't seen any company that can replicate their technology or bypass their technological barriers. They still have to pay the protection fees they are supposed to pay."
Furthermore, the protection fees we pay to Kechuang Biotechnology ultimately pass on the pressure of price increases to downstream businesses, who then pass it on to consumers.
Just by doubling the range, it's not unreasonable for new energy vehicles to increase their price by 100,000 yuan, right?
The price increases in upstream lithium carbonate over the past few years have ultimately been passed on to consumers, haven't they?
Whether the price increase of upstream raw materials can be passed on to consumers is not so certain.
Companies with bargaining power can raise prices proactively. For example, when lithium prices rose, Tesla had some bargaining power and was able to raise prices first.
Some domestic new energy vehicle manufacturers focus on cost-effectiveness, so if they raise prices without authorization, it will have a significant impact on sales.
Even Tesla's price increase was timed to coincide with a surge in oil prices.
If the price of new energy vehicles rises too sharply, consumers will choose to buy gasoline cars, which are far more mature than new energy vehicles.
Therefore, the conclusion that the price increase of upstream raw materials is passed on to consumers is a deduction made from the perspective of the end of 2023.
It's about finding the process in the result.
"Speaking of technology for replicating scientific and technological innovations, it's not like no one has succeeded. Musk's Neuralink, for example, did it."
"You really believe that Neuralink developed its brain-computer interface technology on its own? Back then, the evidence was so conclusive that it was clear they obtained the technology prototype from Kechuang Bio."
It was only barely made based on the technology of Kechuang Bio, and its recognition accuracy is nowhere near that of Kechuang Bio's brain-computer interface with mobile phones.
They can only rely on price advantages in Samsung's mid-range models.
Kechuang Bio's brain-computer interface technology has gained a foothold in the high-end mobile phone market.
As a result, when domestic and international Android phone brands hold press conferences to launch high-end models, they have to specifically point out that the brain-computer interface technology comes from Kechuang Biotechnology.
The frequency with which Kechuang Bio's logo appears is comparable to that of Qualcomm.
After Apple and Kechuang Bio partnered to launch brain-computer interface phones globally, both of China's two major mobile phone manufacturers, OPPO and Vivo, approached them.
They expressed their desire to become a strategic partner of Kechuang Biotechnology, merely a nominal partner, and were willing to pay hundreds of millions of yuan annually for this nominal partnership.
If you can provide some technical support, that would be best. If not, I would also like to ask them to print the Kechuang Bio logo on the back of the phone in their promotional materials.
OV has taken marketing to the extreme, by displaying the logo of its innovative biotechnology company on the back, which attracts many digital enthusiasts.
In recent years, Kechuang Bio's status in the domestic digital circle is comparable to that of Apple.
Just like how Hua Wei placed Leica in the background back then, the publicity effect was greater than the actual effect.
For OV, hiring celebrities for marketing is a waste of money anyway, and collaborating with Kechuang Biotechnology is also a form of marketing.
Allocating a portion of the annual marketing budget to this area is perfectly harmless.
"In fact, there have been countless papers on graphene coatings in recent years. Everyone knows that graphene will definitely have a revolutionary effect in batteries."
Including the three-dimensional structure, everyone guessed it.
However, no one has figured out how to construct a three-dimensional graphene coating. If it is only a 3D model, it is impossible to judge the effect of such a graphene coating.
It's not convincing.
Only Kechuang Biotechnology can follow this technology and bring the actual product to life for everyone to see, just like this.
As for the graphene coating manufacturing equipment of Kechuang Biotechnology, I estimate it is some kind of more advanced 3D printing equipment. We'll have to wait until it arrives to know the specific effects.
Thinking about it this way, Kechuang Biotechnology is really amazing; they can solve things that everyone else can't.
"Isn't that obvious? Endorphins and brain-computer interfaces—which of these things did someone else figure out? Zheng Li is, after all, a top student who published in Nature in his freshman year."
My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!
Continue read on readnovelmtl.com
